Avis Stock Short Squeeze Drives Wild Price Swings

Avis stock short squeeze sent shares from a record intraday peak into a sharp unwind, exposing concentrated hedge-fund bets and heavy short interest.

April 23, 2026·2 min read
View all news articles
Flat filled vector of a car silhouette under strain to represent an Avis stock short squeeze and hedge-fund buildup.

KEY TAKEAWAYS

  • Institutional accumulation sparked a short squeeze that hit an intraday $847.70 peak on April 22.
  • Short interest was 86.2% of the free float as of April 21, heightening covering risk.
  • Two firms' combined equity and derivatives exposure reached about 108% of shares outstanding, roughly 35 million equivalents.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Avis stock short squeeze pushed Avis Budget Group (CAR) shares to an intraday peak on April 22, 2026, before a sharp unwind the next day, highlighting concentrated hedge-fund accumulation and outsized short positions that trapped sellers.

Squeeze Mechanics and Price Moves

Shares surged to an intraday high of $847.70 on April 22, then closed down 37.8% at $443.94, marking the largest single-day percentage drop since April 1998. Short interest in CAR stock was estimated at 86.2% of the free float as of April 21, leaving short sellers vulnerable to rapid covering as available shares tightened.

Two institutional holders, SRS Investment Management and Pentwater Capital, accounted for much of the pressure. Their combined equity and derivatives exposure reached about 108% of the company’s total shares outstanding, roughly 35 million share equivalents. The squeeze was driven by institutional accumulation rather than retail buying, trapping short sellers and prompting rapid position unwinds into April 23.

The price action unfolded despite weak company fundamentals flagged by analysts, including heavy leverage, competition from ride-sharing services, and tariff-related fleet costs. These factors left the rally detached from the business outlook.

Analyst and Regulatory Response

A regulatory disclosure filed April 21 detailed Pentwater Capital’s beneficial ownership in Avis Budget, intensifying scrutiny of concentrated positions. On April 23 at 10:13 a.m. ET, a report described a “prisoners’ dilemma” among hedge funds inflating the stock’s valuation, which increased pressure to unwind positions.

Brokerage desks responded swiftly. Deutsche Bank downgraded the stock to Hold with a $128 target, Barclays to Underweight with a $150 target, and JPMorgan to Underweight with a $165 target. Analysts cited a valuation disconnected from the company’s operating fundamentals and no operational catalyst to support the post-squeeze price.

Investor concern about a potential equity offering and dilution added to selling pressure on April 23, pushing the stock into price-discovery mode. The extreme short interest combined with dominant institutional accumulation created the technical conditions for the spike and abrupt reversal. The stock’s path depends on how quickly large holders reduce positions and whether dilution fears ease.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Apple CEO John Ternus Faces Siri and Talent Tests

Apple CEO John Ternus Faces Siri and Talent Tests

Apple CEO John Ternus faces an early iPhone launch and a Siri overhaul that traders will watch for signals on product cadence and talent risk.

Charter Q1 2026 Results Signal Weak Broadband

Charter Q1 2026 Results Signal Weak Broadband

Charter Q1 2026 results show revenue decline and larger-than-expected broadband losses that produced an EPS miss and complicate capital plans.

Google to Invest in Anthropic in Up to $40B Deal

Google to Invest in Anthropic in Up to $40B Deal

Google to Invest in Anthropic reshapes private AI valuations and cloud ties; a $10B initial and up-to-$40B pledge alters private-market pricing.

X-Energy IPO Debuts on Nasdaq

X-Energy IPO Debuts on Nasdaq

X-Energy IPO set a strong Nasdaq open after an upsized, heavily subscribed offering, boosting early valuation and concentrating near-term trader flows.

Regeneron MFN Deal Lowers Prices, Offers Free Gene Therapy

Regeneron MFN Deal Lowers Prices, Offers Free Gene Therapy

Regeneron MFN deal cuts U.S. drug prices and offers Otarmeni free while securing tariff relief, and may push investors to reprice launch economics.

Tesla Cybercab Production Begins at Gigafactory Texas

Tesla Cybercab Production Begins at Gigafactory Texas

Tesla Cybercab production shifts robotaxi revenue timing and positioning as company cites $0.20 per mile economics and sub-$30,000 price targets.